Subscribe: Market Wire - Medical and Healthcare: Mental Health
http://img.marketwire.com/rss/mwMHMH.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
announced  annual  company  corp  health  jan  marketwired jan  marketwired  medical  naltrexone  new  otc pink  product  provider  sanchez 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Mental Health

Marketwired - Mental Health



Marketwired - Mental Health



Last Build Date: Wed, 18 Jan 2017 08:33:10 EST

Copyright: Copyright: (C) Marketwired
 



MediXall Appoints Dr. Pedro A. Sanchez, D.O., to be its First Medical Director

Wed, 18 Jan 2017 07:30:00 EST

FT. LAUDERDALE, FL--(Marketwired - Jan 18, 2017) - MediXall Group, Inc. (OTCQB: MDXL) is pleased to announce the appointment of its first Medical Director, Dr. Pedro A. Sanchez, D.O. Dr. Sanchez is a graduate of Southeastern College of Osteopathic Medicine in Ft. Lauderdale, Florida, and served his residency at Wellington Regional Medical Center in Wellington, Florida. Dr. Sanchez is Board Certified by the American Osteopathic Board of Family Physicians, and has been a successful family practice physician for over 25 years.




Helix BioPharma Corp. Announces Voting Results from Its Annual and Special Meeting of Shareholders

Tue, 17 Jan 2017 17:05:00 EST

TORONTO, ONTARIO--(Marketwired - Jan. 17, 2017) - Helix BioPharma Corp. (TSX:HBP) (FRANKFURT:HBP) ("Helix"), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announced today the results of matters voted on at its annual and special meeting of shareholders held on January 17, 2017 (the "Meeting").




CB Insights Reveals the AI 100 List At The Innovation Summit

Tue, 17 Jan 2017 11:00:00 EST

CloudMedx Inc Selected to the 2017 AI 100, Highlighting Advancements in Clinical AI Insights at All Points of Care




Advantis Corp. Boosts Bottom Line, Reduces Debt

Tue, 17 Jan 2017 09:26:00 EST

NEWPORT BEACH, CA--(Marketwired - Jan 17, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) announced that it has settled into its new commercial space to meet surging demand of Amstercan, rosin presses, and other products. The company has also announced that it has reduced debt by $250,000.




PHZIO Telehealth Clinic Orientation and On-boarding

Tue, 17 Jan 2017 09:00:00 EST

CULVER CITY, CA--(Marketwired - Jan 17, 2017) - eWellness Healthcare Corporation, (OTCQB: EWLL) is the first telehealth company for physical therapy to offer insurance reimbursable remotely monitored physical therapy (PT) treatments. The Company is pleased to announce that it has begun clinic orientation and on-boarding of selected PT's at Motion PT Group and our other previously announced PT clinic licensees. More information about our telehealth solution is available at our PHZIO.COM website: https://www.phzio.com




Study Shows Improved Primary Adherence as high as 99% using InstyMeds Automated Direct-to-Patient Dispensers

Tue, 17 Jan 2017 07:00:00 EST

MINNEAPOLIS, MN--(Marketwired - Jan 17, 2017) - A 2017 study conducted at the University of Minnesota and published in the journal ClinicoEconomics and Outcomes Research found patients that have their medications dispensed at the point of care have much higher rates of adherence.




Proto Script Pharmaceutical Corp. discusses Opportunities in the Expanding US Power Wheelchair and Mobility Scooter Market

Tue, 17 Jan 2017 06:00:00 EST

RANCHO CUCAMONGA, CA--(Marketwired - Jan 17, 2017) - Proto Script Pharmaceutical Corp. dba PSP Homecare ("PSP" or the "Company") (OTC PINK: PSCR), a durable medical equipment provider, is pleased to provide this discussion regarding opportunities in the expanding US power wheelchair and mobility scooter market.




The Steadman Clinic, SPRI and Smith & Nephew Host Annual Vail Hip Symposium

Fri, 13 Jan 2017 18:25:39 EST

Three-day Event at Westin Riverfront Resort Highlights Latest Methods of Treating Hip Injuries and Rehabilitation




Global Alzheimer's Platform Foundation Appoints Cyndy Cordell as Vice President of Provider Relations

Fri, 13 Jan 2017 09:00:00 EST

Healthcare Veteran To Drive Alzheimer's Clinical Trial Participation And Research




Warriors Heart Offers Help Keeping New Year's Resolution to Remain Sober

Thu, 12 Jan 2017 16:15:29 EST

Central Texas Treatment Center Focuses on Helping Service Members and First Responders Overcome Addictions




CloudHealth Genomics Presents HealthySeq, the World's First Whole Genome Sequencing Liquid Biopsy Test for Healthy Individuals

Thu, 12 Jan 2017 10:27:02 EST

BOSTON, MA and SHANGHAI, CHINA--(Marketwired - Jan 12, 2017) - CloudHealth Genomics, a leading genomics-based precision medicine solutions provider in China, presented data today for the launch of HealthySeq, the world first whole genome next generation sequencing (NGS)-based liquid biopsy test designed to establish a genomic baseline for healthy individuals for a scientific health/wellness management perspective at the 9th Annual Biotech ShowcaseT, which occurs concurrently to the 35th Annual JP Morgan Healthcare Conference in San Francisco, CA.




Starkey Hearing Technologies to Launch Complete Ear Health Product Line

Thu, 12 Jan 2017 09:00:00 EST

New product line seeks to improve overall hearing health and reduce the time individuals wait to address hearing issues




BioCorRx Retains Innovative Science Solutions to Guide FDA Regulatory Process for its Naltrexone Products

Thu, 12 Jan 2017 07:30:00 EST

ANAHEIM, CA--(Marketwired - Jan 12, 2017) - BioCorRx Inc. (OTC PINK: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced it has retained Innovative Science Solutions, LLC, ("ISS") a leading scientific consulting firm, headquartered in Morristown, New Jersey to help guide the Company's regulatory strategy for the submission of its sustained release naltrexone product(s) to the U.S. Food and Drug Administration (FDA). The company's injectable naltrexone product, BICX101 is being developed under its BioCorRx Pharmaceuticals subsidiary in partnership with TheraKine, Ltd and is currently in preclinical development. The company also owns two, already developed, naltrexone pellet products which are implanted subcutaneously.




StemExpress v. Center for Medical Progress Lawsuit Dismissed

Wed, 11 Jan 2017 19:19:19 EST

StemExpress dismisses complaint and walks away from lawsuit




Medovex Corporation Enters into International Distribution Agreement with AlfaMed s.r.l., Italy

Wed, 11 Jan 2017 12:30:00 EST

Leading Supplier of Innovative Spine Surgery Equipment to Distribute the DenerveX(TM) System throughout Italy